Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
J&J's immunology portfolio compensates for Stelara's LOE
J&J's recent growth surge has come despite the LOE of Stelara. Compensating for the shortfall is Tremfya, which topped the $2 billion mark in Q2.
Kevin Dunleavy
Jul 15, 2026 11:30am
Veradermics reports ph. 2 win in female pattern hair loss
Jul 15, 2026 11:27am
Decision readiness is the next AI advantage
Brought to you by
The Directions Group
Kelun's sac-TMT win offers blueprint for Merck's global gap
Jul 15, 2026 10:20am
9 of the Top 10 Pharma Manufacturers Choose Redi Health
Brought to you by
Redi Health
Bora inks $2.5B deal with drug discovery AI specialist Insilico
Jul 15, 2026 7:08am
